IL2 and tuberculosis: We found that ZOL/IL-2 administration in Group-2 macaques after MDR-TB infection/TB drug treatment induced significantly greater percentage and absolute numbers of Vγ2Vδ2 T cells in PBMC until week 14, when compared to controls (Figure 3(A)).